Back to discover
Disease

Spasm

Late-stage therapeutic developmentEmerging research
1
Publications
19
Clinical trials
2020
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma.

Research2020-07-24Journal of clinical oncology : official journal of the American Society of Clinical Oncology

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Clinical trials

17 sponsors · 1 new · 2 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
19
All trials
6
Active
13
Late-stage
6
Completed
Late-stage studies
Recently completed

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020 · 373 cites
Recent publications

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020 · 373 cites
Leading journals1
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology1
Leading researchers8
  • Bahary N1
  • Bates SE1
  • Bullock AJ1
  • Chondros D1
  • de la Fouchardiere C1
  • Fazio N1
  • Hammel P1
  • Heinemann V1
Affiliations (unnormalised)6
  • and Université de Paris1
  • Beth Israel Deaconess Medical Center1
  • Catalan Institute of Oncology (ICO)1
  • Centre Léon Bérard1
  • Columbia University Irving Medical Center1
  • Department of Internal Medicine III and Comprehensive Cancer Center1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

An involuntary contraction of a muscle or group of muscles. Spasms may involve SKELETAL MUSCLE or SMOOTH MUSCLE.

Identifiers
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.